FDA
-
-
-
-
-
-
-
Lifeward Successfully Closes on Strategic Partnership with Oramed
-
-
-
-
-
-
-
Lifeward to acquire upper body exoskeleton technology for $480,000
-
-
-
-
-
-
-
Oramed to transfer drug delivery tech to Lifeward for 49.9% stake
-
-
-
-
-
-
-
UnitedHealthcare Medicare Advantage Plan Issues Prior Authorization Approval for a ReWalk 7 Personal Exoskeleton
-
-
-
-
-
-
-
Lifeward Names Almog Adar as New CFO, Strengthening Executive Leadership
-
-
-
-
-
-
-
Lifeward Ltd. Reports First Quarter 2025 Financial Results
-
-
-
-
-
-
-
FDA Issues Clearance for ReWalk 7 Exoskeleton
-
322,238 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

